What is the long-term trend for Indivior Pharmaceuticals, Inc. 's customer refunds and credits?

Over 2 years (2023 to 2025), Indivior Pharmaceuticals, Inc. 's customer refunds and credits has grown at a 4.3% compound annual growth rate (CAGR), from $535M to $582M.

Indivior Pharmaceuticals, Inc. INDV Customer refunds and credits

Customer refunds and credits at other companies

WEC Energy GroupWEC

$10.9M+2,082%

Southern CompanySO

$5M+105%

CMS

CMS EnergyCMS

$0-100%

WEC Energy GroupWEC

$10.9M+2,082%

National Fuel GasNFG

$303.2M+0.3%

Service Corporation InternationalSCI

$34.25M-3.1%

Other financials

Income statement

See full

Revenue$317.0M+19.2%

Gross profit$277.0M+24.8%

Operating income$137.0M+108%

Net income$89.0M+89.4%

EPS (diluted)$0.69+81.6%

Balance sheet

See full

Cash & equivalents$175.0M-53.0%

Total debt$509.0M+37.6%

Total equity-$144.0M+49.5%

Total assets$1.2B-12.9%

Cash flow

See full

Operating cash flow-$9.0M-112%

CapEx$20.0M+300%

Free cash flow-$29.0M-141%

Valuation

See full

Market cap$4.53B+213%

Profitability

See full

Gross margin81.3%+1.5pp

Operating margin25.8%+23.3pp

Net margin19.4%+18.9pp

FCF margin-14.9%—

Returns & leverage

See full

Current ratio0.9×0.0×

Where this comes from

Reported directly by Indivior Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerRefundLiabilityCurrent.

The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Indivior Pharmaceuticals, Inc. 's customer refunds and credits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Indivior Pharmaceuticals, Inc. 's customer refunds and credits?: Indivior Pharmaceuticals, Inc. (INDV) reported customer refunds and credits of $551M in Q1 2026.
How has Indivior Pharmaceuticals, Inc. 's customer refunds and credits changed year-over-year?: Indivior Pharmaceuticals, Inc. 's customer refunds and credits decreased by 18.4% year-over-year, from $675M to $551M.
What is the long-term trend for Indivior Pharmaceuticals, Inc. 's customer refunds and credits?: Over 2 years (2023 to 2025), Indivior Pharmaceuticals, Inc. 's customer refunds and credits has grown at a 4.3% compound annual growth rate (CAGR), from $535M to $582M.